Interethnic variation in lipid profiles: Implications for underidentification of African-Americans at risk for metabolic disorders

Expert Review of Endocrinology and Metabolism

Volumn 7, Issue 6, 2012, Pages 659-667

  Bentley, Amy R ^a   Rotimi, Charles N ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

African American; epidemiology; genomics; health disparities; insulin resistance; lipids; metabolic syndrome

Indexed keywords

ANTILIPEMIC AGENT; LIPID; PRAVASTATIN; SIMVASTATIN;

AFRICAN AMERICAN; AREA UNDER THE CURVE; CARDIOVASCULAR DISEASE; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; HEALTH DISPARITY; HEREDITY; HUMAN; LIFESTYLE; LIPID BLOOD LEVEL; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 84869801422     PISSN: 17446651     EISSN: 17448417     Source Type: Journal    
DOI: 10.1586/eem.12.55     Document Type: Review

References (67)

1. Hurley LP, Dickinson LM, Estacio RO, Steiner JF, Havranek EP. Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors. Circ. Cardiovasc. Qual. Outcomes 3(2), 181-187 (2010).
2. Gu Q, Burt VL, Paulose-Ram R, Yoon S, Gillum RF. High blood pressure and cardiovascular disease mortality risk among U.S. adults: the third National Health and Nutrition Examination Survey mortality follow-up study. Ann. Epidemiol. 18(4), 302-309 (2008).
3. Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 29(6), 1263-1268 (2006).
4. Chang M-H, Ned REM, Hong Y et al. Racial/ethnic variation in the association of lipid-related genetic variants with blood lipids in the US adult population / clinical perspective. Circulation: Cardiovascular Genetics 4(5), 523-533 (2011).
5. Dai S, Fulton JE, Harrist RB, Grunbaum JA, Steffen LM, Labarthe DR. Blood lipids in children: age-related patterns and association with body-fat indices: Project HeartBeat! Am. J. Prev. Med. 37(Suppl. 1), S56-S64 (2009).
6. Lamb MM, Ogden CL, Carroll MD, Lacher DA, Flegal KM. Association of body fat percentage with lipid concentrations in children and adolescents: United States, 1999-2004. Am. J. Clin. Nutr. 94(3), 877-883 (2011).
7. CDC. Prevalence of abnormal lipid levels among youths - United States, 1999-2006. Morb. Mort. Wkly Rep. 2010(59), 29-33 (2010).
8. D'Adamo E, Northrup V, Weiss R et al. Ethnic differences in lipoprotein subclasses in obese adolescents: importance of liver and intraabdominal fat accretion. Am. J. Clin. Nutr. 92(3), 500-508 (2010).
9. Giannini C, Santoro N, Caprio S et al. The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care 34(8), 1869-1874 (2011).
10. Miljkovic-Gacic I, Bunker CH, Ferrell RE et al. Lipoprotein subclass and particle size differences in Afro-Caribbeans, African Americans, and white Americans: associations with hepatic lipase gene variation. Metab. Clin. Exp. 55(1), 96-102 (2006).
11. Johnson JL, Slentz CA, Duscha BD et al. Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study. Atherosclerosis 176(2), 371-377 (2004).
12. Adeyemo A, Gerry N, Chen G et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet. 5(7), e1000564 (2009).
13. Rotimi CN, Dunston GM, Berg K et al. In search of susceptibility genes for Type 2 diabetes in West Africa: the design and results of the first phase of the AADM study. Ann. Epidemiol. 11(1), 51-58 (2001).
14. CDC. National health and nutrition examination protocol. National Health and Nutrition Examination Protocol (2003-2004).
15. CDC. National health and nutrition examination protocol. National Health and Nutrition Examination Protocol (2007-2008).
16. Kant AK, Graubard BI. Race-ethnic, family income, and education differentials in nutritional and lipid biomarkers in US children and adolescents: NHANES 2003-2006. Am. J. Clin. Nutr. 96(3), 601-612 (2012).
17. Walker SE, Gurka MJ, Oliver MN, Johns DW, DeBoer MD. Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors. Nutr. Metab. Cardiovasc. Dis. 22(2), 141-148 (2012).
18. Raffensperger S, Kuczmarski MF, Hotchkiss L, Cotugna N, Evans MK, Zonderman AB. Effect of race and predictors of socioeconomic status on diet quality in the HANDLS Study sample. J. Natl Med. Assoc. 102(10), 923-930 (2010).
19. Deshmukh-Taskar PR, O'Neil CE, Nicklas TA et al. Dietary patterns associated with metabolic syndrome, sociodemographic and lifestyle factors in young adults: the Bogalusa Heart Study. Public Health Nutr. 12(12), 2493-2503 (2009).
20. Clarke PJ, O'Malley PM, Johnston LD, Schulenberg JE, Lantz P. Differential trends in weight-related health behaviors among American young adults by gender, race/ethnicity, and socioeconomic status: 1984-2006. Am. J. Public Health 99(10), 1893-1901 (2009).
21. Pan Y, Pratt CA. Metabolic syndrome and its association with diet and physical activity in US adolescents. J. Am. Diet. Assoc. 108(2), 276-286; discussion 286 (2008).
22. Luke A, Dugas L, Durazo-Arvizu R, Cao G, Cooper R. Assessing physical activity and its relationship to cardiovascular risk factors: NHANES 2003-2006. BMC Public Health 11(1), 387 (2011).
23. Troiano RP, Berrigan D, Dodd KW, Mâsse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med. Sci. Sports Exerc. 40(1), 181-188 (2008).
24. Furtado JD, Campos H, Sumner AE, Appel LJ, Carey VJ, Sacks FM. Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial. Am. J. Clin. Nutr. 92(4), 714-722 (2010).
25. Howard BV, Curb JD, Eaton CB et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative Dietary Modification Trial. Am. J. Clin. Nutr. 91(4), 860-874 (2010).
26. Monda KL, Ballantyne CM, North KE. Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the Atherosclerosis Risk in Communities Study. J. Lipid Res. 50(8), 1685-1691 (2009).
27. Hosain GM, Rahman M, Williams KJ, Berenson AB. Racial differences in the association between body fat distribution and lipid profiles among reproductive-age women. Diabetes Metab. 36(4), 278-285 (2010).
28. Després JP, Couillard C, Gagnon J et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler. Thromb. Vasc. Biol. 20(8), 1932-1938 (2000).
29. Raman A, Sharma S, Fitch MD, Fleming SE. Anthropometric correlates of lipoprotein profile and blood pressure in high BMI African American children. Acta Paediatr. 99(6), 912-919 (2010).
30. Sumner AE, Vega GL, Genovese DJ, Finley KB, Bergman RN, Boston RC. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metab. Clin. Exp. 54(7), 902-909 (2005).
31. Chow CC, Periwal V, Csako G et al. Higher acute insulin response to glucose may determine greater free fatty acid clearance in African-American women. J. Clin. Endocrinol. Metab. 96(8), 2456-2463 (2011).
32. Hasson RE, Adam TC, Davis JN et al. Ethnic differences in insulin action in obese African-American and Latino adolescents. J. Clin. Endocrinol. Metab. 95(8), 4048-4051 (2010).
33. Gower BA, Herd SL, Goran MI. Antilipolytic effects of insulin in African American and white prepubertal boys. Obes. Res. 9(3), 224-228 (2001).
34. Deo RC, Reich D, Tandon A et al. Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study. PLoS Genet. 5(1), e1000342 (2009).
35. Romeo S, Yin W, Kozlitina J et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J. Clin. Invest. 119(1), 70-79 (2009).
36. Romeo S, Pennacchio LA, Fu Y et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat. Genet. 39(4), 513-516 (2007).
37. Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc. Med. 18(1), 6-14 (2008).
38. Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466(7307), 707-713 (2010).
39. Adeyemo A, Bentley A, Meilleur K et al. . Transferability and fine mapping of genome-wide associated loci for lipids in African Americans. BMC Med. Genet. 13(1), 88 (2012).
40. Chang MH, Yesupriya A, Ned RM, Mueller PW, Dowling NF. Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey. BMC Med. Genet. 11, 62 (2010).
41. Adeyemo A, Rotimi C. Genetic variants associated with complex human diseases show wide variation across multiple populations. Public Health Genomics 13(2), 72-79 (2010).
42. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329(5993), 841-845 (2010).
43. Freedman BI, Langefeld CD, Murea M et al. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrol. Dial. Transplant. 26(11), 3805-3810 (2011).
44. Bentley AR, Doumatey AP, Chen G et al. Variation in APOL1 contributes to ancestry-level differences in HDLcHDLkidney function association. Int. J. Nephrol. 2012(11), 10 (2012).
45. Love-Gregory L, Sherva R, Sun L et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum. Mol. Genet. 17(11), 1695-1704 (2008).
46. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354(12), 1264-1272 (2006).
47. Mbikay M, Mayne J, Seidah NG, Chrétien M. Of PCSK9, cholesterol homeostasis and parasitic infections: possible survival benefits of loss-of-function PCSK9 genetic polymorphisms. Med. Hypotheses 69(5), 1010-1017 (2007).
48. Simon JA, Lin F, Hulley SB et al. Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am. J. Cardiol. 97(6), 843-850 (2006).
49. Goldberg RB, Guyton JR, Mazzone T et al. Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with Type 2 diabetes and hypercholesterolemia. Diabetes Care 33(5), 1021-1024 (2010).
50. Mangravite LM, Medina MW, Cui J et al. Combined influence of LDLR and HMGCR sequence variation on lipidlowering response to simvastatin. Arterioscler. Thromb. Vasc. Biol. 30(7), 1485-1492 (2010).
51. Ho RH, Choi L, Lee W et al. Effect of drug transporter genotypes on pravastatin disposition in European- and African- American participants. Pharmacogenet. Genomics 17(8), 647-656 (2007).
52. Margolis KL, Dunn K, Simpson LM et al.; ALLHAT Collaborative Research Group. Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the Antihypertensive and Lipid Lowering to Prevent Heart Attack Trial (ALLHATLLT). Am. Heart J. 158(6), 948-955 (2009).
53. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am. J. Med. 119(10), 812-819 (2006).
54. Sumner AE. Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. J. Pediatr. 155(3), S7.e7-S7.11 (2009).
55. Gaillard T. Insulin resistance and cardiovascular disease risk in black people of the African Diaspora. Curr. Cardiovasc. Risk Rep. 4(3), 186-194 (2010).
56. Dagogo-Jack I, Dagogo-Jack S. Dissociation between cardiovascular risk markers and clinical outcomes in African Americans: need for greater mechanistic insight. Curr. Cardiovasc. Risk Rep. 5(3), 200-206 (2011).
57. Osei K. Metabolic syndrome in blacks: are the criteria right? Curr. Diab. Rep. 10(3), 199-208 (2010).
58. Gower BA, Ard JD, Hunter GR, Fernandez J, Ovalle F. Elements of the metabolic syndrome: association with insulin sensitivity and effects of ethnicity. Metab. Syndr. Relat. Disord. 5(1), 77-86 (2007).
59. Goedecke JH, Utzschneider K, Faulenbach MV et al. Ethnic differences in serum lipoproteins and their determinants in South African women. Metab. Clin. Exp. 59(9), 1341-1350 (2010).
60. Li C, Ford ES, Meng YX, Mokdad AH, Reaven GM. Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovasc. Diabetol. 7, 4 (2008).
61. Stein E, Kushner H, Gidding S, Falkner B. Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome. Metab. Clin. Exp. 56(7), 954-960 (2007).
62. Gaillard T, Schuster D, Osei K. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome. Metab. Clin. Exp. 59(8), 1115-1123 (2010).
63. Erqou S, Kaptoge S, Perry PL et al.; Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302(4), 412-423 (2009).
64. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301(22), 2331-2339 (2009).
65. Virani SS, Brautbar A, Davis BC et al. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 125(2), 241-249 (2012).
66. Ridker PM. Lipoprotein(a), ethnicity, and cardiovascular risk: erasing a paradox and filling a clinical gap. Circulation 125(2), 207-209 (2012).
67. Sharma S, Merchant J, Fleming SE. Lp(a)-cholesterol is associated with HDL-cholesterol in overweight and obese African American children and is not an independent risk factor for CVD. Cardiovasc. Diabetol. 11, 10 (2012).